Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patientsFrancesca Gay, Antonio Palumbo, Pieter Sonneveld et al.|Blood|2011Cited by 268
Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: Updated Follow-Up and Improved SurvivalAntonio Palumbo, Michèle Cavo, Roberto Passera et al.|Journal of Clinical Oncology|2014Cited by 210
Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular LymphomaDaniela Drandi, Marco Ladetto, Lenka Kubiczkova-Besse et al.|Journal of Molecular Diagnostics|2015Cited by 132
Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemiaDavide Rossi, Marco Ladetto, Chiara Lobetti Bodoni et al.|Leukemia|2009Cited by 98
Highly sensitive <i>MYD88</i> <sup>L265P</sup> mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemiaDaniela Drandi, Simone Ferrero, Elisa Genuardi et al.|Haematologica|2018Cited by 84